TEL AVIV, Israel, July 5, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or "the Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today condensed consolidated financial data for...
from PR Newswire: https://ift.tt/2XlfrEE
No comments:
Post a Comment